the alpine trial shows improved outcomes with zanubrutinib versus ibrutinib in r/r cll
Published 2 weeks ago • 96 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
2:58
dr fürstenau on safety data from the gaia/cll13 trial in untreated cll
-
3:00
dr fürstenau on safety data from the gaia/cll13 trial in untreated cll
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
2:15
cd8 t cell expansion in cll patients treated with ibrutinib
-
5:54
updates from captivate: ibrutinib and venetoclax for cll
-
27:48
sam and mom—"evaluation of the child with adhd"
-
9:53
flow cytometry - 4 | cd markers| t cell acute lymphoblastic leukemia & nk cells -- 10 minutes !!!!
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
2:41
btk and plcg2 mutations in cll patients taking ibrutinib
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
4:08
what do real-world data tell us about outcomes with venetoclax/hma vs 7 3 chemotherapy?
-
7:35
targeting cll cell proliferation: clinical overview
-
1:15
promises and challenges in up-and-coming cll therapies
-
1:11
patient selection in the treatment of cll
-
1:43
ongoing clinical trials to look out for in lymphoma
-
8:57
outcomes of sct in t-all and t-lbl
-
3:10
ascend: acalabrutinib in r/r cll
-
10:00
2024eha | targeting cd7 car-t therapy shows efficacy and safety in treating r/r t-all/lbl patients
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
1:43
innovations in the clinical assessment of cll